Regeneron Pharmaceuticals (REGN) FCF Margin (QoQ) (2009 - 2026)

Regeneron Pharmaceuticals (REGN) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,018.00
Mar 31, 2026 -21.00
Dec 31, 2025 -684.00
Sep 30, 2025 -194.00
Jun 30, 2025 557.00
Mar 31, 2025 -112.00
Dec 31, 2024 423.00
Sep 30, 2024 1,435.00
Jun 30, 2024 -3,435.00
Mar 31, 2024 1,943.00
Dec 31, 2023 292.00
Sep 30, 2023 -1,414.00
Jun 30, 2023 -199.00
Mar 31, 2023 -153,009.00
Dec 31, 2022 155,113.00
Sep 30, 2022 219.00
Jun 30, 2022 -390,542.00
Mar 31, 2022 387,502.00
Dec 31, 2021 -5,022.00
Sep 30, 2021 8,649.00